-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

617.P1.42 617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, ALL, AML, Biological, HSCs, Leukemia, survivorship, therapy sequence, Diseases, Non-Biological, Combinations, Therapies, chemotherapy, MDS, Pediatric, Biological Processes, DNA damage, DNA repair, Technology and Procedures, Cell Lineage, cytogenetics, epigenetics, Lymphoid Malignancies, Study Population, Clinically relevant, genetic profiling, genomics, Myeloid Malignancies, hematopoiesis, imaging, Quality Improvement , flow cytometry, transplantation, integrative -omics, molecular testing, NGS, molecular interactions, RNA sequencing, pathogenesis, pathways, proteomics
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Abhishek Maiti, MBBS1, Sergej Konoplev, MD, PhD2*, Courtney D. DiNardo, MD, MSc3, Tapan M. Kadia, MD4, Farhad Ravandi, MBBS5, Naval Daver, MD6, Naveen Pemmaraju, MD1, Gautam Borthakur, MD1, Prithviraj Bose, MD7, Ghayas C. Issa, MD1, Nicholas J. Short, MD1, Musa Yilmaz, MD7, Yesid Alvarado, MD7, Alessandra Ferrajoli, MD8, Elias Jabbour, MD1, Nitin Jain, MD9, Maro Ohanian, DO1*, Koichi Takahashi, MD, PhD10, Philip A. Thompson, MB, MS11, Caitlin R. Rausch, PharmD12*, Kathryn Montalbano13*, Sherry A. Pierce, BSN, BA1*, Keyur P. Patel, MBBS, PhD2, Guillermo Garcia-Manero, MD1, Hagop M. Kantarjian, MD14 and Marina Konopleva, MD, PhD15

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
5Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
7Department of Leukemia, MD Anderson Cancer Center, Houston, TX
8Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
9Associate Professor of Medicine Department of Leukemia The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
11The University of Texas MD Anderson Cancer Center, Houston, TX
12Pharmacy, MD Anderson Cancer Center, Houston, TX
13University of Texas M.D. Anderson Cancer Center, Houston, TX
14University of Texas MD Anderson Cancer Center, Houston, TX
15Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX

Bruno Paiva, PhD1*, María Belén Vidriales2*, Maria Desamparados Sampere Talens3*, Fabian Tarin4*, Enrique Colado5*, Celina Benavente6*, María Teresa Cedena, MD7*, Joaquin Sanchez, MD8*, Teresa Caballero-Velázquez, MD, PhD9*, Lourdes Cordon10*, David Martínez-Cuadron, MD11*, Teresa Bernal del Castillo, MD, PhD12*, Carmen Botella13*, Sofia Grille, MD, PhD14, Josefina Serrano, MD15*, Carlos Rodriguez16*, Jesús Lorenzo Algarra17*, Juan Manuel Alonso Dominguez, MD, PhD, MSc18*, Maria Luz Amigo, MD19*, Manuel BARRIOS García, MD, PhD20*, Raimundo García-Boyero, MD21*, Mercedes Colorado, MD22*, Jaime Perez De Oteyza, MD, PhD23, Manuel Perez Encinas, MD24*, Lissette Del Pilar Costilla, MD25*, Maria Jose Sayas26*, Olga Pérez-López27*, Marcos González28*, Jose A. Perez-Simon, MD, PhD29, Joaquin Martinez-Lopez, MD, PhD30*, Claudia Lucia Sossa31*, Alberto Orfao, MD, PhD32, Jesús F. San-Miguel33, Miguel Sanz, MD, PhD34* and Pau Montesinos, MD, PhD35*

1Clinica Universidad De Navarra, Pamplona, Navarra, Spain
2Instituto de Investigación Biomédica de Salamanca, Hospital Universitario de Salamanca, Salamanca, Spain
3Hospital Universitario y Politécnico La Fe, Valencia, ESP
4Hospital General Universitario De Alicante, Alicante, ESP
5Hospital Universitario Central de Asturias, Oviedo, Spain
6Hospital Clinico San Carlos. Madrid, Madrid, Spain
7Hematology Department, Hospital Universitario 12 de Octubre,, Madrid, Spain
8Hospital Universitario Reina Sofia, Cordoba, Spain
9Department of Hematology, Hospital Universitario Virgen del Rocio; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla,Spain, Sevilla, Spain
10Hospital Universitario La Fe, Valencia, Spain
11Hospital Universitari i Politècnic La Fe, Valencia, Spain
12Central de Asturias Universitary Hospital, Oviedo, Spain
13Hematology department, Hospital General Universitario de Alicante, Alicante, Spain
14Hospital de Clínicas. Montevideo, Montevideo, Uruguay
15University Hospital Reina Sofia, Cordoba, Spain
16Hospital Gran Canaria Dr Negrín, Las Palmas, ESP
17Hospital General de Albacete, Albacete, ESP
18Hospital Universitario Fundacion Jimenez Diaz - IISFJD-UAM, Madrid, Madrid, Spain
19Hematology and Medical Oncology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain, Murcia, ESP
20Hospital Regional Universitario de Málaga, Málaga, ESP
21Hematology and hemotherapy department, Hospital Universitario General de Castellón, Castellón de la Plana, Spain
22Hematology Department, University Hospital "Marqués de Valdecilla", Santander, Spain
23Hospital Universitario Madrid Sanchinarro, Madrid, Spain
24Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
25Hematology, Hospital Miguel Servet. Zaragoza, Zaragoza, Spain
26Hospital Universitario Doctor Peset, Valencia, Spain
27Hospital Universitario Virgen del Rocío, Dos Hermanas, Spain
28Departamento de Hematología, Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain
29Hospitales Univ. Virgen Del Rocío, Virgen De La Macarena, Seville, Spain
30Hematology Department Hospital 12 de Octubre, Complutense University, H12O-CNIO Clinical research unit, CIBERONC, Madrid, Spain
31Hematology and Hematopoietic Stem Cell Transplantation Unit, Clinica FOSCAL, Floridablanca, Santander, Colombia
32University of Salamanca, Salamanca, Salamanca, Spain
33University of Navarra, Pamplona, Spain
34Hematology Department, Hospital Universitario La Fe de Valencia,, Valencia, Spain
35Hematology Department, Hospital Universitario La Fe de Valencia,, Valencia, Spain, Spain

Claudia Nunez-Torron, MD1*, Fernando Martin Moro2*, Juan Marquet Palomanes2*, Miguel Piris-Villaespesa, MD3*, Ernesto Roldan2*, Alejandro Luna, MD3*, Adolfo Saez2*, Valentín Garcia-Gutiérrez, MD, PhD3, Lucía Rubio2*, Maria Eulalia Rodriguez2*, Anabelle Chinea, MD4*, Ana Lario5*, Gemma Moreno Jiménez, MD4*, Javier Lopez Jimenez, MD, PhD6* and Pilar Herrera Puente7*

1Hematology, Hospital Ramon y Cajal, 28034, Spain
2Hospital Universitario Ramón y Cajal, Madrid, Spain
3Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain
4Hematology and Hemotherapy Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
5Hospital Ramón y Cajal, Madrid, Madrid, ESP
6University Hospital Ramon y Cajal, Madrid, Spain
7Hematology department, Hospital Ramón y Cajal, Madrid, Spain

James Yu, MD1, Jingxin Sun, MD, PhD2*, Yuan Du3* and Chung-Che Chang, MD, PhD4

1Internal Medicine Department, Adventhealth Orlando Hospital, Orlando, FL
2Department of Hematology and Medical Oncology, Baylor College of Medicine, Huston, TX
3Research Institute, Adventhealth Orlando Hospital, Orlando, FL
4Hematology and Molecular Pathology Labs, Adventhealth Orlando Hospital, Orlando, FL

Anna Maierhofer, PhD*, Constance Baer, PhD, Christian Pohlkamp, MD*, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD and Torsten Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany

Hassan Awada, MD1*, Carmelo Gurnari, MD2*, Arda Durmaz3*, Simona Pagliuca, MD4, Misam Zawit, MBBS4*, Cassandra M Kerr, MS4* and Valeria Visconte, PhD4

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland
3Department of Systems biology and Bioinformatics, CWRU, cleveland
4Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

Min Yang, MD, PhD1*, Yi Zhang, Medical Master2*, Jinghan Wang, MD, PhD3*, Lixia Liu4*, Chengcheng Wang5*, Feng Lou6*, Shanbo Cao7* and Jie Jin, MD, PhD8

1The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2The First Affiliated Hospital Zhejiang Univ. School of Med, Hangzhou, China
3Key Laboratory of Hematopoietic Malignancies, Zhejiang Province, Hangzhou, China
4Acornmed Biotechnology Co., Ltd., Beijing, China
5AcornMed Biotechnology Co., Ltd., Beijing, China
6AcornMed Biotechnology Co., Ltd.7 Floor, Building 8, Vpark, No.18 Kechuang 13th Street, Beijing, China, Beijing, China
7Acornmed Biotechnology Co.,Ltd., Beijing, China
8Department of Hematology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China

Amy Song1*, Omar Altabbakh, BS2*, David A. Sallman, MD3, Eric Padron, MD4, Chetasi Talati, MD3 and Mohammad O Hussaini, MD5,6*

1New Jersey Medical School, Rutgers University, Newark, NJ
2Nova Southeastern University, Clearwater, FL
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
5Department of Hematopathology and Lab Medicine, 1978, tampa, FL
6Moffitt Cancer Center, Tampa, FL

Sydney Fobare1,2, Jessica Kohlschmidt, PhD1,3, Hatice Gulcin Ozer, PhD4*, Krzysztof Mrózek, MD, PhD1, Deedra Nicolet, MS1,3*, Alice S. Mims, MD1,2, Ramiro Garzon, MD1,2, James S. Blachly, MD1,2, Shelley Orwick, BS1*, Andrew J Carroll, PhD5, Richard M. Stone, MD6, Eunice S. Wang, MD7, Jonathan E. Kolitz, MD8, Bayard L. Powell, MD9, Christopher C. Oakes, PhD1,10, Ann-Kathrin Eisfeld, MD2,11, Erin Hertlein, PhD1,2* and John C. Byrd, MD1,2

1The Ohio State University Comprehensive Cancer Center, Columbus, OH
2Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
3Alliance Statistics and Data Center, The Ohio State University Comprehensive Cancer Center, Columbus, OH
4Department of Biomedical Informatics, The Ohio State University, Columbus, OH
5Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
6Dana-Farber/Partners CancerCare, Boston, MA
7Roswell Park Comprehensive Cancer Center, BUFFALO, NY
8Monter Cancer Center, Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY
9Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC
10OSU, Columbus, OH
11Division of Hematology, The Ohio State University, Columbus, OH

Sean Koebley, PhD1*, Andrey Mikheikin, PhD1*, Kevin Leslie, PhD1*, Wendy McConnell-Wells1*, Joshua H Lehman1*, Daniel Guest1*, Taha Al Juhaishi, MD2*, Xiaojie Zhang, MD2*, Catherine H Roberts, PhD2*, Loren Picco, PhD1*, Amir Ahmed Toor, MD2*, Alden Chesney, MD3 and Jason Reed, PhD1,4*

1Department of Physics, Virginia Commonwealth University, Richmond, VA
2Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA
3Department of Pathology, VCU School of Medicine, Richmond, VA
4Massey Cancer Center, VCU Medical Center, Richmond, VA

Pavinder Kaur1*, Anil Pahuja1*, Kevin Nguyen1*, Pedro Marques Ramos, PhD2*, Ling Du, PhD3*, Jacqueline J Cloos4*, Maaike E Heidinga4*, Yvonne J.M Oussoren-Brockhoff4*, Angele Kelder4*, Xun Li1, Sarah Larson, MD5, Shabnam Tangri1*, Ghanashyam Sarikonda1* and Naveen Dakappagari1*

1Navigate BioPharma Services, Inc., a Novartis subsidiary, Carlsbad, CA
2Novartis International AG, Basel, Switzerland
3Novartis Pharmaceuticals, Cambridge, MA
4Vrije University Medical Center, Amsterdam, Netherlands
5University of California Los Angeles, Los Angeles, CA

Disha Dalela, MD1, Qiming Shi2*, Karl Simin, MD3*, Jonathan Gerber, MD4* and Shyam A. Patel, MD, PhD5*

1Department of Medicine, University of Massachusetts, Shrewsbury, MA
2Department of Population Health & Quantitative Sciences, University of Massachusetts, Worcester, MA
3Department of Molecular, Cell & Cancer Biology, University of Massachusetts, Worcester, MA
4Department of Medicine- Hematology/Oncology, University of Massachusetts, Worcester, MA
5Department of Medicine- Hematology/Oncology, University of Massachusetts, 55 Lake Avenue North, MA

Anneke D. van Dijk, MD1,2*, Fieke W Hoff, BSc1*, Yihua Qiu3*, Eveline S. de Bont, MD, PhD1*, Sophia W.M. Bruggeman, PhD1*, Terzah M Horton, MD, PhD4 and Steven M. Kornblau, MD5

1Department of Pediatric Oncology/ Hematology, University Medical Center Groningen, Groningen, Netherlands
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4Baylor College of Medicine, Houston, TX
5Department of Stem Cell Transplantation, M.D. Anderson Cancer Center University of Texas, Houston, TX

Hang Su1*, Mei-Jun Long, MD, PhD1,2*, Joel E Michalek, PhD1*, Michael Weil, PhD3* and Chul S Ha, MD1

1The University of Texas Health Science Center At San Antonio, San Antonio, TX
2The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
3Colorado State University, Fort Collins, CO

Vitória Ceni Ceni, MD1*, Katia B Pagnano, MD, PhD2, Gislaine B O Duarte, MD2*, Marina DB Pellegrini2*, Bruno Kosa Duarte, MD, PhD2*, Konradin Metze, MD, PhD3* and Irene Lorand-Metze, MD, PhD4*

1Hematology and Hemotherapy Center, University of Campinas, Campinas, AC, Brazil
2Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil
3Department of Pathology, Faculty of Medicine, University of Campinas, Campinas, Brazil
4Department of Internal Medicine, Faculty of Medicine, University of Campinas, CAMPINAS, Brazil

Romy E. Van Weelderen1,2*, Kim Klein, MD3,4*, Bianca F. Goemans, MD, PhD5, Christian M. Zwaan, MD, PhD5,6, Hester A. De Groot-Kruseman, PhD5,7*, Jonas Abrahamsson, MD, PhD8*, Nira Arad-Cohen, MD, PhD9*, Emmanuelle Bart-Delabesse, PharmD, PhD10*, Barbara Buldini, MD, PhD11*, Barbara De Moerloose, MD, PhD12*, Michael Dworzak, MD, PhD13*, Sarah Elitzur, MD14*, José M. Fernández Navarro, MD15*, Robert B. Gerbing, MA16*, Erin Guest, MD17, Shau-Yin Ha, MD, PhD18*, Christine J. Harrison, PhD, FRCPath19, Henrik Hasle, MD20, Kathy Jackson, MD, PhD21*, Charikleia Kelaidi, MD22*, Hélène Lapillonne, MD, PhD23*, Guy Leverger, MD, PhD24*, Franco Locatelli, MD, PhD25, Takako Miyamura, MD, PhD26, Sophia Polychronopoulou, MD, PhD22*, Mareike Rasche, MD27*, Jeffrey E. Rubnitz, MD28, Jan Stary, MD, PhD29*, Daisuke Tomizawa, MD, PhD30, Femke Verwer2,7* and Gertjan J.L. Kaspers, Prof. MD, PhD3,5

1Department of Pediatric Hematology and Oncology, Emma Children’s Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
2Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
3Department of Pediatric Hematology and Oncology, Emma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
4Wilhelmina Children’s Hospital/University Medical Center Utrecht, Utrecht, Netherlands
5Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
6Department of Pediatric Oncology/Hematology, Erasmus University Medical Center-Sophia Children’s Hospital, Rotterdam, Netherlands
7Dutch Childhood Oncology Group, Utrecht, Netherlands
8Department of Pediatrics, Queen Silvia Children's Hospital, Gothenburg, Sweden
9Pediatric Hematology Oncology Department, Ruth Rappaport Children’s Hospital, Rambam Health Care Campus, Haifa, Israel
10Laboratoire d'Hématologie secteur Génétique des Hémopathies, IUC Toulouse-Oncopole, Toulouse, France
11Pediatric Hematology-Oncology, Department of Women's and Children's Health, University of Padova, Padova, Italy
12Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium
13St. Anna Children's Hospital and Cancer Research Institute, Medical University of Vienna, Vienna, Austria
14Pediatric Hematology and Oncology, Schneider Children's Medical Center and Tel Aviv University, Tel Aviv, Israel
15Pediatric Oncohematology Unit, Hospital Universitari i Politècnic la Fe, Valencia, Spain
16Children's Oncology Group, Monrovia, CA
17Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy, Kansas City, MO
18Department of Pediatrics, Queen Mary Hospital, Hong Kong, Hong Kong
19Leukaemia Research Cytogenetics Group, Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, ENG, United Kingdom
20Pediatrics, Aarhus University Hospital, Aarhus, Denmark
21St. Jude Children’s Research Hospital, Memphis, TN
22Department of Pediatric Hematology and Oncology, Aghia Sophia Children’s Hospital, Athens, Greece
23Pediatric Hematology and Oncology Department, Hôpital Armand Trousseau, Paris, France
24Pediatric Hematology and Oncology Department, Hôpital Armand-Trousseau, Paris, France
25Department of Pediatric Hematology/Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
26Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan
27Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany
28Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
29Department of Pediatric Hematology and Oncology, University Hospital Motol, Prague, Czech Republic
30Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan

Lars Bullinger, MD1, Javier Martinez Elicegui2*, Eric Sträng, PhD3*, Castellani Gastone4*, Caroline A Heckman, PhD5, Ana Heredia Casanoves6*, Jurjen Versluis7*, Moritz Gerstung, PhD8*, María Abáigar, PhD9*, Alberto Hernandez-Sanchez2*, Laura Jamilis6*, Raúl Azibeiro Melchor2*, Peter JM Valk, PhD10, Klaus H. Metzeler, MD11, Rosa Ayala, MD, PhD12*, Joaquin Martinez Lopez13*, Hervé Dombret, MD14, Pau Montesinos, MD, PhD15*, Jorge Sierra, MD16, Claude Preudomme17*, Frederik Damm, MD18*, Ken I Mills, PhD, FRCPath, BSc19, Jiri Mayer20*, Christian Thiede, MD21, Maria Teresa Voso, MD22, Sergio Amadori23, Guillermo F Sanz, MD, PhD24, Frederico Calado25*, Konstanze Dohner, MD26, Verena I Gaidzik, MD27, Michael Heuser28, Torsten Haferlach, MD29, Marta Sobas, MD PhD30*, Amin T. Turki, MD, PhD31, Dirk Reinhardt, MD32, Rubén Villoria Medina6*, Michel van Speybroeck, MSc33*, Renate Schulze-Rath, MD, MSc34*, Jesús M Hernández Rivas, MD, PhD9, Brian J. P. Huntly, PhD, MRCP, MB, FRCPath35, Hartmut Döhner27 and Gert J. Ossenkoppele, MD, PhD36

1Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany
2Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain
3Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine Berlin, Berlin, Germany
4University of Bologna (UNIBO), Bologna, Italy
5Institute for Molecular Medicine Finland,, University of Helsinki, Helsinki, Finland
6GMV Innovating Solutions, Valencia, Spain
7Erasmus University Medical Center Cancer Institute, Rotterdam, Rotterdam, Netherlands
8European Bioinformatics Institute, Hinxton, United Kingdom
9Universidad de Salamanca, IBSAL, Centro de Investigación del Cáncer, IBMCC-CSIC, Salamanca, Spain
10Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands
11Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
12Hematology Department, Hospital Universitario 12 de Octubre,, Madrid, Spain
13Hospital Universitario 12 de Octubre, Madrid, Spain
14Division of Hematology, EA3518 Saint-Louis Institute for Research, Hôpital Saint-Louis, APHP, University of Paris, Paris, France, Paris, France
15Hematology Department, Hospital Universitario La Fe de Valencia,, Valencia, Spain, Spain
16Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
17University Hospital, Lille, France
18Hematology, Oncology, and Tumorimmunology, Charité - Universitätsmedizin Berlin, Berlin, Germany
19Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, United Kingdom
20University Hospital Brno, Czech Republic, Brno, CZE
21Dept. of Internal Medicine I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
22Dipartimento di Biopatologia e Diagnostica per Immagini, University of Rome Tor Vergata, Rome, Italy
23Department of Biomedicine and Prevention, University of Rome Tor Vergata, Roma, RM, Italy
24Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain
25Novartis, Oncology Region Europe, Basel, Switzerland
26Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
27Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
28Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
29MLL Munchner Leukamie Labor Gmbh, Munchen, Germany
30Department of Hematology, Wroclaw Medical University, Wroclaw, Poland
31Department of Bone Marrow Transplantation, University Hospital Essen, West German Cancer Center, Essen, Germany
32Department of Pediatric Hematology and Oncology, Essen University Hospital, Essen, Germany
33Data Sciences, Janssen Pharmaceutica N.V., Beerse, Belgium
34Bayer Pharma AG, Berlin, Berlin, Germany
35Department of Haematology, University of Cambridge, Cambridge, United Kingdom
36Department of Hematology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands

Lara Duchstein1*, Hillary S Sloane, PhD2*, Johannes Fredebohm, PhD1* and Matthew Ryder2*

1Sysmex Inostics GmbH, Hamburg, Germany
2Sysmex Inostics, Inc., Baltimore, MD

Yasmin Alwash, MD1,2, Rashmi Kanagal-Shamanna, MD3, Veronica A Guerra, MD1, Naval Daver, MD1, Marina Konopleva, MD, PhD1, Farhad Ravandi, MBBS1, Tapan M. Kadia, MD1, Courtney D. DiNardo, MD, MSc1, Ghayas C. Issa, MD4, Gautam Borthakur, MD1, Sanam Loghavi, MD3, Koichi Takahashi, MD, PhD1, Musa Yilmaz, MD4, Abhishek Maiti, MBBS4, Hagop M. Kantarjian, MD5, Steven M. Kornblau, MD1 and Nicholas J. Short, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, Professor and Chairman, Department of Leukemia, Samsung Distinguished University Chair in Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Metis Hasipek, PhD1*, Yihong Guan, PhD1*, Dale Grabowski, BS1*, Xiaorong Gu, PhD1*, Yogenthiran Saunthararajah, MD1, Robert Silverman, PhD2*, George R Stark, PhD2*, Jaroslaw Maciejewski, PhD1* and Babal K. Jha, PhD1*

1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
2Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH

Giulia Maggioni, MD1*, Cristina Astrid Tentori, MD1*, Maria Teresa Voso, MD2, Sonja Heibl, MD3*, Klaus H. Metzeler, MD4, Jan Moritz Middeke, MD5*, Joana Desterro6*, Maria Carmo-Fonseca7*, Erica Travaglino1*, Paola Fazi, MD8*, Alfonso Piciocchi, MS8*, Annika Maria Dufour, PhD4*, Jordi Esteve9*, Marta Pratcorona, MD10*, Valentina Mancini, MD11*, Federico Lussana, MD12*, Karsten Spiekermann13*, Christian Thiede, MD14, Friedrich Stolzel, MD15*, Aida Botelho de Sousa16*, Mar Tormo17*, Pamela Acha18*, Montserrat Arnan19*, Nicola Fracchiolla, MD20*, Marcus Hentrich21*, Christoph Sippel22*, Bernhard Heilmeier23*, Marcos Lemos24*, Albertina Nunes25*, Sonia Matos26*, Marina Diaz9*, Ana Garrido, MD10*, David Gallardo, MD27*, Susana Vives, MD28*, Olga Salamero29*, Elisabetta Todisco, MD PhD30*, Claudia Basilico, MD31*, Francesco Passamonti32*, Sigrid Machherndl-Spandl, MD33*, Lisa Pleyer34*, Jorge Sierra35*, Francesc Solé, PhD36 and Matteo Giovanni Della Porta, MD1*

1Cancer Center, IRCCS Humanitas Research Hospital & Humanitas University, Rozzano (Milan), Italy
2University of Rome Tor Vergata, Rome, Italy
3Dept. of Internal Medicine IV, Klinikum Wels-Grieskirchen GmbH, Wels, Austria
4Laboratory for Leukemia Diagnostics, Department of Hematology and Oncology, University Hospital, LMU Munich, Munich, Germany
5Dept. of Internal Medicine I, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
6Instituto Portugues de Oncologia de Lisboa, Servico de Hematologia, Lisboa, Portugal
7Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Portugal, Lisboa, Portugal
8GIMEMA Foundation, Rome, Italy
9Hematology Dpt. Hospital Clínic, Barcelona, Barcelona, Spain
10Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
11Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
12Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Please Choose A State, Italy
13Dept. of Hematology and Oncology, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany
14Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany
15Department of Hematology and Oncology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
16Hospital dos Capucho, Lisboa, Portugal
17Hematology Dpt., Hospital Clínico Universitario, Valencia, Spain
18Hematology Dpt, Hospital Germans Trias y Pujol, Catalan Institute of Oncology, Badalona and Jose Carreras Leukemia Research Institute, Badalona, Spain
19Hematology Dpt., Hospital Duran Reynals, Catalan Institute of Oncology, Hospitalet, Barcelona, Spain
20UOC Oncoematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Di, Milan, ITA
21Dept. of Hematology and Oncology,, Red Cross Hospital, Munich, Germany
22Hematology Dpt., Hospital Clínic, Barcelona, Barcelona, Spain
23Department of Oncology and Hematology, Hospital Barmherzige Brueder, Regensburg, Germany
24Hospital dos Capuchos, Centro Hospitalar Lisboa Central, Lisboa, Portugal
25Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal
26GenoMed - Diagnósticos de Medicina Molecular SA, Lisboa, Portugal
27Hematology Department, ICO - Hospital Doctor Josep Trueta, Girona, Spain
28Hematology Department, ICO - Hospital Germans Trias i Pujol, Badalona, Spain
29Hematology Dpt. Hospital Vall d'Hebron, Barcelona, Spain
30European Institute of Oncology, Milano, Italy
31ASST dei Sette Laghi, Presidio di Varese Osp Circolo Fondazione Macchi, Varese, Italy
32Division of Hematology, Department of Medicine and Surgery, University of Insubria, Varese, Italy
331st. Internal Department – Hematology with stem cell transplants, hemostaseology and medical oncology, Elisabethinen Hospital, Linz, Austria
343rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Paracelsus Medical University, Salzburg, Austria, Salzburg, Austria
35Hematology Dpt. Hospital Santa Creu i Sant Pau, Barcelona, Spain
36MDS Research Group, Institut de Recerca Contra la Leucèmia Josep Carreras, Institut Català d’Oncologia-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Badalona, Spain

Catia Patricia Simoes, MD1*, Bruno Paiva, PhD2*, David Martínez-Cuadron, MD3*, Juan-Miguel Bergua, MD4*, Susana Vives, MD5*, Jesús Lorenzo Algarra6*, Mar Tormo, MD7, Pilar Martinez, MD8*, Josefina Serrano, MD9*, Pilar Herrera, MD10*, Fernando Ramos11*, Olga Salamero, MD12*, Esperanza Lavilla13*, Cristina Gil14*, Jose Luiz Lopez Lorenzo, MD15*, Maria-Belen Vidriales, MD16*, Jorge Labrador17*, José F. Falantes18*, Maria Jose Sayas19*, Rosa Ayala, MD, PhD20*, Joaquin Martinez-Lopez, MD21*, Sara Villar22*, María José Calasanz, PhD23*, Felipe Prosper, MD24*, Jesús F. San-Miguel25, Miguel A. Sanz26 and Pau Montesinos, MD, PhD27*

1Clinica Universidad De Navarra, Centro De Investigacion Medica Aplicada (CIMA),, Pamplona, Spain
2Clinica Universidad De Navarra, Pamplona, Navarra, Spain
3Hospital Universitari i Politècnic La Fe, Valencia, Spain
4Clinical Hematology, Hospital San Pedro de Alcántara, Cáceres, Spain
5Hematology Department, ICO - Hospital Germans Trias i Pujol, Badalona, Spain
6Hematology department, Complejo Hospitalario Universitario de Albacete, Albacete, Spain
7Hospital Clínico Universitario de Valencia, Valencia, Spain
8Haematology department, 12 Octubre Hospital, Madrid, Spain
9University Hospital Reina Sofia, Cordoba, Spain
10Hematology and Hemotherapy Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
11Department of Hematology, Hospital Universitario De LeóN and Instituto De Biomedicina (IBIOMED), Un, Leon, Spain
12Department of Hematology, University Hospital Vall d´Hebron, Barcelona, Spain
13Hospital Universitario Lucus Augusti, Lugo, Spain
14Hematology Department, Hospital General Universitario de Alicante, Alicante, Spain
15Fundación Jiménez Díaz, Madrid, Madrid, Spain
16Hematology Department, Hospital Clínico Universitario Salamanca (CAUSA/IBSAL), Salamanca, Spain
17Hematology Department, Research Unit, Hospital Universitario de Burgos, Burgos, Spain
18Hospital Universitario Virgen del Rocío, Sevilla, Spain
19Hospital Dr. Peset. Spain, Valencia, Spain
20Hematology Department, Hospital Universitario 12 de Octubre,, Madrid, Spain
21Hematology and hemotherapy department, Hospital Universitario 12 De Octubre, Madrid, Spain
22Hematology Department, Clínica Universidad de Navarra, Universidad de Navarra, Pamplona, Spain
23University of Navarra, Pamplona, Na, ESP
24CLINICA UNIVERSIDAD DE NAVARRA - DPTO. HEMATOLOGIA, Pamplona, Navarra, Spain
25University of Navarra, Pamplona, Spain
26Hematology Department, University and Polytechnic Hospital La Fe, Valencia, Spain
27Hematology Department, Hospital Universitario La Fe de Valencia,, Valencia, Spain, Spain

Xue Chen, MD1,2*, Fang Wang, MD2, Panxiang Cao, MS2*, Xiaoli Ma, MD2*, Lili Yuan, MD2*, Yang Zhang, MD2, Daijing Nie, MD2*, Jiaqi Chen, MD2*, Xiaosu Zhou2*, Ming Liu, MD2*, Zhixiu Liu, MD2*, Mingyue Liu2* and Hongxing Liu, MD2,3,4

1Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Beijing, China
2Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China
3Beijing Lu Daopei Institute of Hematology, Beijing, China
4Division of Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China

Casey L. McAtee, MD1*, Joseph Lubega, MBChB, MPH2*, Michael E. Scheurer, PhD, MPH3* and Rachel E. Rau, MD4

1Department of Pediatrics, Division of Hematology/Oncology, Baylor College of Medicine/Texas Children's Hospital, Houston, TX
2Texas Children's Cancer and Hematology Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
3Texas Children's Hospital, Houston, TX
4Texas Children’s Cancer and Hematology Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX

Ludovic Gabellier, MD1,2,3*, Caroline Bret, PhD, PharmD4,5,6*, Guillaume Bossis, PhD2*, Guillaume Cartron, MD, PhD7,8,9* and Jerome Moreaux, PhD6,10,11,12

1Department of clinical Hematology, University Hospital of Montpellier, Montpellier, France
2Institut de Génétique Moléculaire de Montpellier (IGMM), CNRS, Montpellier, France
3UFR Medicine, University of Montpellier, Montpellier, France
4Department of Biological Hematology, CHU Montpellier, Montpellier, France
5University of Montpellier, UFR Medecine, Montpellier, France
6Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France
7CHU Montpellier, Department of Clinical Hematology, Montpellier, France
8Centre Hospitalier Universitaire de Montpellier, Montpellier, France
9Department of Clinical Hematology, University Hospital of Montpellier, Montpellier, France
10UFR Médecine, Université Montpellier, Montpellier, France
11Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, CHU Montpellier, Montpellier, France
12Institut Universitaire de France, Paris, France

Fieke W Hoff, BSc1*, Anneke D. van Dijk, MD1*, Yihua Qiu2*, Eveline S. de Bont, MD, PhD1*, Steven M. Kornblau, MD3 and Terzah M Horton, MD, PhD4

1Department of Pediatric Oncology/ Hematology, University Medical Center Groningen, Groningen, Netherlands
2Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Baylor College of Medicine, Houston, TX

Jenny L. Smith, MSc, MEd1*, Eline J.M. Bertrums, MD2*, Rhonda E. Ries, MA1*, Fabiana Ostronoff, MD3, Amanda R. Leonti, MS4*, Scott N. Furlan, MD3,5*, Bianca F. Goemans, MD, PhD2 and Soheil Meshinchi, MD, PhD6,7,8

1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
3Fred Hutchinson Cancer Research Center, Seattle, WA
4Clinical Research Division, Fred Hutchinson Cancer Research Center, Mountlake Terrace, WA
5Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA
6Department of Pediatrics, University of Washington, Seattle, WA
7Clinical Research Division, Fred Hutchinson Cancer Rsrch. Ctr., Seattle, WA
8Children's Oncology Group, Monrovia, CA

Svea Stratmann1*, Sara A Yones2*, Jitong Sun, PhD1*, Aron Skaftason3*, Markus Mayrhofer, PhD4*, Nina Norgren, PhD5*, Morten Krogh Herlin, MD6*, Anna Eriksson, PhD7*, Martin Hoglund, MD7, Josefine Palle, PhD8*, Kirsi Jahnukainen, MD, PhD9*, Katja Pokrovskaja Tamm, PhD10*, Lucia Cavelier, PhD1* and Linda Holmfeldt, PhD1,11*

1Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
2Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden
3Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
4National Bioinformatics Infrastructure Sweden, Science For Life Laboratory, Uppsala, Sweden
5Department of Molecular Biology, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Umeå University, Umeå, Sweden
6Aarhus University Hospital, Aarhus, Denmark
7Department of Medical Sciences, Uppsala University, Uppsala, Sweden
8Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden
9Children's Hospital, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
10Department of Oncology and Pathology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
11The Beijer Laboratory, Uppsala University, Uppsala, Sweden

Sanam Loghavi, MD1, Courtney D. DiNardo, MD, MSc2, Koichi Takahashi, MD, PhD3, Rashmi Kanagal-Shamanna, MD4, Tomoyuki Tanaka, MD, PhD5*, Ken Furudate, DDM, PhD3*, Nicholas J. Short, MD3, Tapan M. Kadia, MD3, Marina Konopleva, MD, PhD3, Noushin Farnoud, PhD6*, Sherry A. Pierce, BSN, BA3*, Joseph D. Khoury, MD1, Jeffrey L. Jorgensen, MD, PhD7*, Keyur P. Patel, MBBS, PhD7, L. Jeffrey Medeiros, MD1, Hagop M. Kantarjian, MD8, Farhad Ravandi, MBBS9 and Sa A Wang, MD7*

1Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Hematopathology, Division of Pathology/Lab Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
6Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
8University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH